Autor der Publikation

Multicenter, Open‐Label, Randomized Phase II Controlled Trial of an Investigational Recombinant Meningococcal Serogroup B Vaccine With and Without Outer Membrane Vesicles, Administered in Infancy

, , , , , , , , , , , , und . Clinical Infectious Diseases, 51 (10): 1127--1137 (November 2010)
DOI: 10.1086/656741

Bitte wählen Sie eine Person um die Publikation zuzuordnen

Um zwischen Personen mit demselben Namen zu unterscheiden, wird der akademische Grad und der Titel einer wichtigen Publikation angezeigt. Zudem lassen sich über den Button neben dem Namen einige der Person bereits zugeordnete Publikationen anzeigen.

 

Weitere Publikationen von Autoren mit dem selben Namen

Seroprevalence of antibodies against serogroup C meningococci in England in the postvaccination era, , , , , , und . Clinical and Vaccine Immunology: CVI, 15 (11): 1694--8 (November 2008)PMID: 18827191.Serological Basis for Use of Meningococcal Serogroup C Conjugate Vaccines in the United Kingdom: Reevaluation of Correlates of Protection, , , und . Infection and Immunity, 69 (3): 1568--1573 (März 2001)PMID: 11179328 PMCID: 98057.Prevention of meningococcal serogroup C disease by NeisVac-C, und . Expert Review of Vaccines, 8 (3): 265--279 (März 2009)PMID: 19249967.Genetics of capsule O-acetylation in serogroup C, W-135 and Y meningococci, , , , , , , und . Molecular Microbiology, 51 (1): 227--239 (Januar 2004)PMID: 14651624.Long term effects of vaccination of patients deficient in a late complement component with a tetravalent meningococcal polysaccharide vaccine, , , , und . Vaccine, 21 (27-30): 4437--4447 (Oktober 2003)PMID: 14505927.Kinetics of Antibody Persistence following Administration of a Combination Meningococcal Serogroup C and Haemophilus influenzae Type b Conjugate Vaccine in Healthy Infants in the United Kingdom Primed with a Monovalent Meningococcal Serogroup C Vaccine, , , , , , , , , und . Clin. Vaccine Immunol., 17 (1): 154--159 (Januar 2010)Serogroup B and C Serum Bactericidal Assays, und . Meningococcal Vaccines: Methods and Protocols, Volume 66 von Methods in Molecular Medicine, Humana Press Inc., Totowa, NJ, (Juni 2001)Multicenter, Open‐Label, Randomized Phase II Controlled Trial of an Investigational Recombinant Meningococcal Serogroup B Vaccine With and Without Outer Membrane Vesicles, Administered in Infancy, , , , , , , , , und 3 andere Autor(en). Clinical Infectious Diseases, 51 (10): 1127--1137 (November 2010)Meningococcal surrogates of protection--serum bactericidal antibody activity, , und . Vaccine, 23 (17-18): 2222--2227 (März 2005)PMID: 15755600.Immunogenicity of 2 Investigational Serogroup B Meningococcal Vaccines in the First Year of Life, , , , , , , , , und 2 andere Autor(en). The Pediatric Infectious Disease Journal, (2010)